Details of the Drug Reposition

General Information of This Drug (ID: DMCBIKO)

• Drug Name: ADCT-402 (DMCBIKO)

Information on Drug Reposition of This Drug

2 Phase 1 Indication(s)

Indication Name	Indication ID	ICD-11	Status	REF
Acute lymphoblastic leukaemia	DIS87TGM	2A85	Phase 1	[1]
B-cell non-hodgkin lymphoma	DISUB5FB	2B33.5	Phase 1	[1]

References

• [1] Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)